Research and analysis

Air pollution: link with COVID-19 infection and adverse outcomes

COMEAP summary of the science linking long-term air pollution exposure with SARS-CoV-2 infection and adverse COVID-19 outcomes.

From:
UK Health Security Agency
Published
6 September 2023

Documents

Ref: UKHSA publications gateway number GOV-15329

PDF, 895 KB, 45 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Ref: UKHSA publications gateway number GOV-15329

PDF, 316 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The statement from the Committee on the Medical Effects of Air Pollutants (COMEAP) evaluates the current 鈥榮tate of the science鈥� on the association between air pollution and COVID-19. It focuses on individual-level studies linking long-term exposure to air pollution with SARS-CoV-2 infection and COVID-19 outcomes in human populations (epidemiological studies) and on studies of how air pollution might affect the body鈥檚 response to the virus (mechanistic studies).

In the working paper, COMEAP is trialling an approach to provide an assessment and visual representation of the strength of the evidence for causality between long-term exposure to PM2.5 and severity of COVID-19 outcomes following infection with SARS-CoV-2.

Updates to this page

Published 6 September 2023

Sign up for emails or print this page

Related content